Loss of melanoregulin (MREG) enhances cathepsin-D secretion by the retinal pigment epithelium

Abstract Cathepsin-D (Cat-D) is a major proteolytic enzyme in phagocytic cells. In the retinal pigment epithelium (RPE), it is responsible for the daily degradation of photoreceptor outer segments (POSs) to maintain retinal homeostasis. Melanoregulin (MREG)-mediated loss of phagocytic capacity has been linked to diminished intracellular Cat-D activity. Here, we demonstrate that loss of MREG enhances the secretion of intermediate Cat-D (48 kDa), resulting in a net enhancement of extracellular Cat-D activity. These results suggest that MREG is required to maintain Cat-D homeostasis in the RPE and likely plays a protective role in retinal health. In this regard, in the Mregdsu/dsu mouse, we observe increased basal laminin. Loss of the Mregdsu allele is not lethal and therefore leads to slow age-dependent changes in the RPE. Thus, we propose that this model will allow us to study potential dysregulatory functions of Cat-D in retinal disease.

[1]  K. Nagashima,et al.  Melanoregulin, Product of the dsu Locus, Links the BLOC-Pathway and Oa1 in Organelle Biogenesis , 2012, PloS one.

[2]  M. Fukuda,et al.  Melanoregulin regulates retrograde melanosome transport through interaction with the RILP–p150Glued complex in melanocytes , 2012, Journal of Cell Science.

[3]  L. da Cruz,et al.  Induction of differentiation by pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19. , 2011, Investigative ophthalmology & visual science.

[4]  C. Serhan,et al.  Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1 , 2010, Journal of Lipid Research.

[5]  A. Cuervo,et al.  Chaperone‐mediated autophagy in health and disease , 2010, FEBS letters.

[6]  K. Palczewski,et al.  Phagocytosis of retinal rod and cone photoreceptors. , 2010, Physiology.

[7]  C. Lillo,et al.  Melanoregulin (MREG) Modulates Lysosome Function in Pigment Epithelial Cells* , 2009, Journal of Biological Chemistry.

[8]  H. Kalbacher,et al.  Cathepsin D: a cellular roadmap. , 2008, Biochemical and biophysical research communications.

[9]  Martin Fusek,et al.  Cathepsin D--many functions of one aspartic protease. , 2008, Critical reviews in oncology/hematology.

[10]  M. Hendrix,et al.  IFN‐γ regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells , 2008, Journal of cellular biochemistry.

[11]  S. Karpatkin,et al.  Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. , 2008, Cancer research.

[12]  N. Banik,et al.  New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. , 2008, CNS & neurological disorders drug targets.

[13]  F. Gaunitz,et al.  Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures. , 2008, European journal of cell biology.

[14]  G. Abecasis,et al.  Inflammation in the pathogenesis of age-related macular degeneration , 2008, British Journal of Ophthalmology.

[15]  F. Panza,et al.  Short arm of chromosome 11 and sporadic Alzheimer's disease: Catalase and cathepsin D gene polymorphisms , 2008, Neuroscience Letters.

[16]  G. Bernardi,et al.  Cathepsin D expression is decreased in Alzheimer's disease fibroblasts , 2008, Neurobiology of Aging.

[17]  N. Copeland,et al.  The tetraspanin protein peripherin-2 forms a complex with melanoregulin, a putative membrane fusion regulator. , 2007, Biochemistry.

[18]  C. McCarty,et al.  Characteristics of progression of early Age-related macular degeneration: the Cardiovascular Health and Age-related maculopathy Study , 2007, Eye.

[19]  Ashok Kumar,et al.  Intracellular HIV-Tat Expression Induces IL-10 Synthesis by the CREB-1 Transcription Factor through Ser133 Phosphorylation and Its Regulation by the ERK1/2 MAPK in Human Monocytic Cells* , 2006, Journal of Biological Chemistry.

[20]  G. Braun,et al.  Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles. , 2006, Experimental eye research.

[21]  A. Lehesjoki,et al.  Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. , 2006, Brain : a journal of neurology.

[22]  P. Saftig,et al.  Cathepsin D deficiency is associated with a human neurodegenerative disorder. , 2006, American journal of human genetics.

[23]  J. Yates,et al.  Proteomic analysis of mature melanosomes from the retinal pigmented epithelium. , 2006, Journal of proteome research.

[24]  C. Curcio,et al.  Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. , 2005, Investigative ophthalmology & visual science.

[25]  V. Vetvicka,et al.  Dual role of cathepsin D: ligand and protease. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[26]  G. Abecasis,et al.  Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.

[27]  N. Copeland,et al.  dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Kellokumpu,et al.  Defective Acidification of Intracellular Organelles Results in Aberrant Secretion of Cathepsin D in Cancer Cells* , 2004, Journal of Biological Chemistry.

[29]  J. Sears,et al.  Accumulation of oxidized lipid-protein complexes alters phagosome maturation in retinal pigment epithelium , 2004, Cellular and Molecular Life Sciences CMLS.

[30]  J. Sears,et al.  Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium. , 2004, Biochimica et biophysica acta.

[31]  M. Zarbin Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[32]  David S. Williams,et al.  Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  William C Hahn,et al.  Lentivirus-delivered stable gene silencing by RNAi in primary cells. , 2003, RNA.

[34]  C. Curcio,et al.  Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.

[35]  H. Nakanishi,et al.  Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice , 2003, Molecular and Cellular Neuroscience.

[36]  I. Constable,et al.  Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. , 2002, The American journal of pathology.

[37]  G. Hoppe,et al.  Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE. , 2001, Investigative ophthalmology & visual science.

[38]  Dean P. Jones,et al.  Oxidative damage and protection of the RPE , 2000, Progress in Retinal and Eye Research.

[39]  C. Delcourt,et al.  Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. , 1999, Ophthalmology.

[40]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[41]  I. Constable,et al.  Modulation of cathepsin D activity in retinal pigment epithelial cells. , 1997, The Biochemical journal.

[42]  Marcel Garcia,et al.  Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis , 1996, Stem cells.

[43]  I. Constable,et al.  Correlation between autofluorescent debris accumulation and the presence of partially processed forms of cathepsin D in cultured retinal pigment epithelial cells challenged with rod outer segments. , 1996, Experimental eye research.

[44]  L. Hjelmeland,et al.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.

[45]  C. Peters,et al.  Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. , 1995, The EMBO journal.

[46]  H. Rochefort,et al.  Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. , 1994, Experimental cell research.

[47]  K. von Figura,et al.  Proteolytic processing of cathepsin D in prelysosomal organelles. , 1994, European journal of cell biology.

[48]  V. Vetvicka,et al.  Effect of human procathepsin D on proliferation of human cell lines. , 1994, Cancer letters.

[49]  Y. Moriyama,et al.  Acidification of phagosomes and degradation of rod outer segments in rat retinal pigment epithelium. , 1994, Investigative ophthalmology & visual science.

[50]  D. Bok,et al.  Phagocytosis of outer segments by retinal pigment epithelium: phagosome-lysosome interaction. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[51]  S. Kornfeld,et al.  Lysosomal enzyme targeting. , 1990, Biochemical Society transactions.

[52]  A. Hasilik,et al.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. , 1980, The Journal of biological chemistry.

[53]  M. Lavail Circadian nature of rod outer segment disc shedding in the rat. , 1980, Investigative ophthalmology & visual science.

[54]  S. Hayasaka,et al.  Degradation of rod outer segment proteins by cathepsin D. , 1975, Journal of biochemistry.

[55]  T. Thorpe A Manual of Qualitative Analysis , 1870, Nature.

[56]  V. Vetvicka,et al.  Procathepsin D and cytokines influence the proliferation of lung cancer cells. , 2011, Anticancer research.

[57]  G. Abecasis,et al.  Toll-like receptor 4 variant D 299 G is associated with susceptibility to age-related macular degeneration , 2005 .

[58]  Emma J. Blott,et al.  Secretory lysosomes , 2002, Nature Reviews Molecular Cell Biology.

[59]  I. Constable,et al.  Initiation of impaired outer segment degradation in vivo using an antisense oligonucleotide. , 1996, Current eye research.

[60]  I. Constable,et al.  Targeted delivery of an antisense oligonucleotide in the retina: uptake, distribution, stability, and effect. , 1996, Antisense & nucleic acid drug development.

[61]  J. Woessner Specificity and biological role of cathepsin D. , 1977, Advances in experimental medicine and biology.